These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29644344)

  • 1. Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.
    MacKenzie TA; Løberg M; O'Malley AJ
    Obs Stud; 2016 Mar; 2():29-50. PubMed ID: 29644344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.
    McNamee R
    Stat Med; 2009 Sep; 28(21):2639-52. PubMed ID: 19579227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
    Antonelli J; Han B; Cefalu M
    Stat Med; 2017 Dec; 36(29):4604-4615. PubMed ID: 28833307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating causal effects of internet interventions in the context of nonadherence.
    Hesser H
    Internet Interv; 2020 Sep; 21():100346. PubMed ID: 32983907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.
    MacKenzie TA; Martinez-Camblor P; O'Malley AJ
    BMC Med Res Methodol; 2021 Mar; 21(1):56. PubMed ID: 33743583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.
    Loeys T; Goetghebeur E
    Biometrics; 2003 Mar; 59(1):100-5. PubMed ID: 12762446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.
    Ye C; Beyene J; Browne G; Thabane L
    BMJ Open; 2014 Jun; 4(6):e005362. PubMed ID: 24939814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the average causal effect among subgroups defined by post-treatment variables.
    Matsuyama Y; Morita S
    Clin Trials; 2006; 3(1):1-9. PubMed ID: 16539085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
    Kubo Y; Sterling LR; Parfrey PS; Gill K; Mahaffey KW; Gioni I; Trotman ML; Dehmel B; Chertow GM
    Pharm Stat; 2015; 14(3):242-51. PubMed ID: 25851955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.